Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and...
Change of Director's Interest Notice
Filed with ASX · · 3 pages · English
Release
Neurizon Therapeutics Limited on 6ix
Earlier from Neurizon Therapeutics
- Notification of cessation of securities - NUZ
- Neurizon Announces Partial Redemption of Convertible Notes
- Application for quotation of securities - NUZ
- NIH funds Expanded Access Program for NUZ-001 in ALS
- Neurizon Appoints Chief Executive Officer
Later from Neurizon Therapeutics
- Dr Chris Bremer commences as Neurizon CEO
- FDA Type C Feedback, HEALEY trial potentially registrational
- Updated Investor Presentation and Webinar Reminder
- Change of AGM Date
- Notice of Annual General Meeting/Proxy Form
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics